-
November 3: The Week in Cancer News
Recommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and children with Down syndrome and leukemia face worse outcomes.
by Marci A. Landsmann
-
October 27: The Week in Cancer News
Living alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’
by Kevin McLaughlin
-
October 20: The Week in Cancer News
Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond to chemotherapy and immunotherapy can forgo surgery.
by Thomas Celona
-
October 13: The Week in Cancer News
Rising prevalence of non-melanoma skin cancer leads to more deaths across the globe, and siblings of cancer patients struggle to ask for help.
by Eric Fitzsimmons
-
October 6: The Week in Cancer News
Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.
by Marci A. Landsmann
-
September 29: The Week in Cancer News
Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.
by Kevin McLaughlin
-
September 22: The Week in Cancer News
Study links proper dental hygiene to increased survival in head and neck cancer, and researchers use breast milk to detect breast cancer in new mothers.
by Thomas Celona
-
September 15: The Week in Cancer News
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
by Eric Fitzsimmons
-
September 8: The Week in Cancer News
Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.
by Marci A. Landsmann
-
September 1: The Week in Cancer News
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and a cancer drug is among 10 selected for price negotiations with Medicare to lower costs.
by Kevin McLaughlin
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona